Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter. Life and ...

An investor group led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc have sold their equity stake in Pharmaceutics International, Inc, a Hunt Valley, ...

SG Americas Securities LLC reduced its holdings in Jabil Inc. (NYSE:JBL – Free Report) by 70.7% during the fourth quarter, ...

Flex Ltd.'s 3Q25 earnings exceeded expectations, with significant growth in data center revenue. Learn why FLEX stock is a ...

Jabil (JBL) reachead $163.62 at the closing of the latest trading day, reflecting a +1.11% change compared to its last close.

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...

The deal complements Jabil’s specialty in injectable drug delivery systems, like those used for popular GLP-1 diabetes drugs ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...